This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Berger R, Le Coniat M, Romana SP, Jonveaux P . Secondary acute myeloblastic leukemia with t(16;21)(q24;q22) involving the AML1 gene Hematol Cell Ther 1996 38: 183–186
Gamou T, Kitamura E, Hosoda F, Shimizu K, Shinohara K, Hayashi Y, Nagase T, Yokoyama Y, Ohki M . The partner gene of AML1 in t(16;21) myeloid malignancies is a novel member of the MTG8 (ET0) family Blood 1998 91: 4028–4037
Pedersen-Bjergaard J, Philip P . Balanced translocations involving bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukemia following therapy with cytostatic agents targeting at DNA topoisomerase-II Blood 1991 78: 1147–1148
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Salomon-Nguyen, F., Busson-Le Coniat, M., Lafage Pochitaloff, M. et al. AML1-MTG16 fusion gene in therapy-related acute leukemia with t(16;21)(q24;q22); two new cases. Leukemia 14, 1704–1705 (2000). https://doi.org/10.1038/sj.leu.2401885
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401885
This article is cited by
-
Compatibility of RUNX1/ETO fusion protein modules driving CD34+ human progenitor cell expansion
Oncogene (2019)
-
Myeloid neoplasms with t(16;21)(q24;q22)/RUNX1-RUNX1T3 mimics acute myeloid leukemia with RUNX1-RUNX1T1
Annals of Hematology (2018)
-
Identification of a new translocation that disrupts the RUNX1 gene in a patient with de novo acute myeloid leukemia
Medical Oncology (2012)
-
AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML
Oncogene (2001)